337 | Humans |
229 | Lymphedema |
209 | Female |
165 | Male |
153 | Middle Aged |
136 | Adult |
107 | Aged |
94 | Animals |
51 | Elephantiasis, Filarial |
43 | Breast Neoplasms |
40 | Lymphatic Vessels |
37 | Treatment Outcome |
37 | Adolescent |
36 | Aged, 80 and over |
34 | Diagnosis, Differential |
31 | Postoperative Complications |
31 | Leg |
29 | Follow-Up Studies |
28 | Young Adult |
25 | Lymphatic System |
25 | Lymph Node Excision |
22 | Time Factors |
22 | Syndrome |
22 | Combined Modality Therapy |
21 | Retrospective Studies |
19 | Quality of Life |
19 | Magnetic Resonance Imaging |
19 | Lymphography |
19 | Drainage |
19 | Child |
19 | Arm |
18 | Lymph Nodes |
17 | Wuchereria bancrofti |
17 | Skin Neoplasms |
17 | Lymphatic Metastasis |
17 | Lymphangiogenesis |
16 | Lymphoscintigraphy |
16 | Filaricides |
16 | Edema |
16 | Contrast Media |
16 | Chronic Disease |
14 | Microsurgery |
14 | Elephantiasis |
13 | Physical Therapy Modalities |
13 | Brugia |
12 | Surveys and Questionnaires |
12 | Radiotherapy, Adjuvant |
12 | Prospective Studies |
12 | Neoplasms |
11 | Tomography, X-Ray Computed |
11 | Scrotum |
11 | Recurrence |
11 | Mice |
11 | Mastectomy |
11 | Genital Diseases, Male |
11 | Disease Models, Animal |
11 | Child, Preschool |
11 | Biopsy |
10 | Venous Insufficiency |
10 | Transplantation, Autologous |
10 | Sensitivity and Specificity |
10 | Onchocerciasis |
10 | Germany |
10 | Endothelial Cells |
10 | Brugia malayi |
9 | Ultrasonography |
9 | Survival Analysis |
9 | Skin |
9 | Risk Factors |
9 | Risk Assessment |
9 | Prognosis |
9 | Phenotype |
9 | Neoplasm Recurrence, Local |
9 | Mutation |
9 | Lymphatic Diseases |
9 | Lymph |
9 | Lower Extremity |
9 | Infant |
9 | Hemangiosarcoma |
9 | Gadolinium DTPA |
9 | Axilla |
9 | Anti-Bacterial Agents |
8 | Wolbachia |
8 | Reproducibility of Results |
8 | Regeneration |
8 | Rats |
8 | Polymerase Chain Reaction |
8 | Neoplasm Staging |
8 | Ivermectin |
8 | Drug Administration Schedule |
8 | Doxycycline |
8 | Cross-Sectional Studies |
8 | Chemotherapy, Adjuvant |
8 | Anastomosis, Surgical |
7 | Wound Healing |
7 | Pain |
7 | Pain Measurement |
7 | Microfilariae |
7 | Lymphangiosarcoma |
7 | Infant, Newborn |
7 | Imaging, Three-Dimensional |
7 | Filariasis |
7 | Breast |
7 | Adipose Tissue |
7 | Abnormalities, Multiple |
6 | Venous Thrombosis |
6 | Vascular Endothelial Growth Factor Receptor-3 |
6 | Surgical Flaps |
6 | Soft Tissue Neoplasms |
6 | Severity of Illness Index |
6 | Radiotherapy |
6 | Postoperative Care |
6 | Pleural Effusion |
6 | Lymphangiectasis, Intestinal |
6 | Leg Ulcer |
6 | Karyotyping |
6 | In Situ Hybridization, Fluorescence |
6 | Head and Neck Neoplasms |
6 | Ghana |
6 | Forkhead Transcription Factors |
6 | Filarioidea |
6 | Feasibility Studies |
6 | Enzyme-Linked Immunosorbent Assay |
6 | Biomarkers |
6 | Antibodies, Helminth |
6 | Albendazole |
6 | Age Factors |
5 | Veins |
5 | Vascular Endothelial Growth Factor C |
5 | Swine |
5 | Sodium Selenite |
5 | Reconstructive Surgical Procedures |
5 | Randomized Controlled Trials as Topic |
5 | Radiation Injuries |
5 | Prevalence |
5 | Preoperative Care |
5 | Predictive Value of Tests |
5 | Practice Guidelines as Topic |
5 | Pedigree |
5 | Patient Care Team |
5 | Organometallic Compounds |
5 | Nail Diseases |
5 | Muridae |
5 | Molecular Sequence Data |
5 | Mastectomy, Segmental |
5 | Lymphangioma |
5 | Inguinal Canal |
5 | Immunoglobulin G |
5 | Heterocyclic Compounds |
5 | Heart Failure |
5 | Groin |
5 | Gadolinium |
5 | Extremities |
5 | Dogs |
5 | Diethylcarbamazine |
5 | Cohort Studies |
5 | Cisplatin |
5 | Bandages |
5 | Antineoplastic Combined Chemotherapy Protocols |
5 | Antigens, Helminth |
5 | Anthelmintics |
5 | Algorithms |
4 | Upper Extremity |
4 | Tomography, Emission-Computed, Single-Photon |
4 | Thrombophlebitis |
4 | Testicular Hydrocele |
4 | Telangiectasis |
4 | Symbiosis |
4 | Swine, Miniature |
4 | Survival Rate |
4 | Skin Diseases |
4 | Sentinel Lymph Node Biopsy |
4 | Schistosomiasis |
4 | Sarcoma, Kaposi |
4 | Range of Motion, Articular |
4 | Radiotherapy Dosage |
4 | Prostatic Neoplasms |
4 | Pressure |
4 | Pilot Projects |
4 | Penile Neoplasms |
4 | Penile Diseases |
4 | Patient Satisfaction |
4 | Patient Admission |
4 | Parasitemia |
4 | Palliative Care |
4 | Obesity |
4 | Mouth Neoplasms |
4 | Morbidity |
4 | Mice, Knockout |
4 | Mice, Inbred C57BL |
4 | Melanoma |
4 | Massage |
4 | Malaria |
4 | Magnetic Resonance Angiography |
4 | Longitudinal Studies |
4 | Lipectomy |
4 | Leg Injuries |
4 | Insect Vectors |
4 | Image Processing, Computer-Assisted |
4 | Fatal Outcome |
4 | Erysipelas |
4 | Dose-Response Relationship, Drug |
4 | DNA, Helminth |
4 | Chromosomes, Human, Pair 5 |
4 | Cells, Cultured |
4 | Carcinoma, Squamous Cell |
4 | Antineoplastic Agents |
3 | Vascular Diseases |
3 | Varicose Veins |
3 | Ultrasonography, Doppler, Color |
3 | Tumor Suppressor Proteins |
3 | Thigh |
3 | Thiazoles |
3 | Technetium Tc 99m Aggregated Albumin |
3 | Tanzania |
3 | Surgical Wound Infection |
3 | Subcutaneous Tissue |
3 | Stress, Mechanical |
3 | Stockings, Compression |
3 | Statistics, Nonparametric |
3 | Software |
3 | Soft Tissue Injuries |
3 | Sirolimus |
3 | Selenium |
3 | Sarcoma |
3 | Reagent Kits, Diagnostic |
3 | Reactive Oxygen Species |
3 | Rats, Inbred Lew |
3 | Radiopharmaceuticals |
3 | Pregnancy |
3 | Postphlebitic Syndrome |
3 | Penis |
3 | Pain, Postoperative |
3 | Otorhinolaryngologic Neoplasms |
3 | Onchocerca volvulus |
3 | Neoplasm Metastasis |
3 | Neoplasm Invasiveness |
3 | Negative-Pressure Wound Therapy |
3 | Neck Dissection |
3 | Multivariate Analysis |
3 | Monitoring, Physiologic |
3 | Microcephaly |
3 | Methods |
3 | Mepivacaine |
3 | Mastectomy, Radical |
3 | Macrophages |
3 | Lymphocele |
3 | Lymphangiectasis |
3 | Larva |
3 | Kidney Diseases |
3 | Intellectual Disability |
3 | Injections, Subcutaneous |
3 | Injections, Intradermal |
3 | Indonesia |
3 | Incidence |
3 | Immunosuppressive Agents |
3 | Homeodomain Proteins |
3 | Hindlimb |
3 | HIV Infections |
3 | Graft Survival |
3 | Genotype |
3 | Genetic Predisposition to Disease |
3 | Genes, Dominant |
3 | Gene Deletion |
3 | Foot |
3 | Fluorouracil |
3 | Fistula |
3 | Fatigue |
3 | Fascia |
3 | Extracellular Fluid |
3 | Exercise Therapy |
3 | Evidence-Based Medicine |
3 | Endemic Diseases |
3 | Edema, Cardiac |
3 | Echocardiography |
3 | Drug Therapy, Combination |
3 | Drug Combinations |
3 | Double-Blind Method |
3 | Dose Fractionation |
3 | Diuretics |
3 | Disease-Free Survival |
3 | Dipetalonema Infections |
3 | DNA Mutational Analysis |
3 | Culex |
3 | Compression Bandages |
3 | Comorbidity |
3 | Chromosome Mapping |
3 | Cell Proliferation |
3 | Cell Differentiation |
3 | Case-Control Studies |
3 | Carcinoma, Ductal, Breast |
3 | Capillary Permeability |
3 | Brain |
3 | Benzothiazoles |
3 | Antigens, CD34 |
3 | Antigens, CD31 |
3 | Antibodies, Monoclonal, Humanized |
3 | Anti-Inflammatory Agents, Non-Steroidal |
3 | Anopheles |
3 | Analysis of Variance |
3 | Amputation |
3 | Administration, Oral |
3 | Acute Disease |
3 | Activities of Daily Living |
2 | Zebrafish |
2 | Xanthomatosis |
2 | Whole-Body Counting |
2 | Warts |
2 | Vascular Neoplasms |
2 | Vascular Endothelial Growth Factor Receptor-2 |
2 | Vascular Endothelial Growth Factor A |
2 | Varicose Ulcer |
2 | Uterine Cervical Neoplasms |
2 | Turner Syndrome |
2 | Triiodobenzoic Acids |
2 | Travel |
2 | Trastuzumab |
2 | Transfection |
2 | Transcription Factors |
2 | Thoracic Duct |
2 | Tail |
2 | T-Lymphocytes |
2 | Suture Techniques |
2 | Sheep |
2 | Sex Factors |
2 | Seroepidemiologic Studies |
2 | Self Care |
2 | SOXF Transcription Factors |
2 | Rural Population |
2 | Retroperitoneal Space |
2 | Respiratory Tract Infections |
2 | Reoperation |
2 | Regression Analysis |
2 | Receptor, TIE-2 |
2 | Receptor Protein-Tyrosine Kinases |
2 | Real-Time Polymerase Chain Reaction |
2 | Rats, Sprague-Dawley |
2 | Radionuclide Imaging |
2 | Radiography |
2 | Radiation-Protective Agents |
2 | ROC Curve |
2 | RNA, Small Interfering |
2 | RNA, Messenger |
2 | Quality Indicators, Health Care |
2 | Public Health |
2 | Proportional Hazards Models |
2 | Practice Patterns, Physicians' |
2 | Postoperative Period |
2 | Platelet-Rich Plasma |
2 | Pigmentation Disorders |
2 | Phytotherapy |
2 | Pericardial Effusion |
2 | Penicillins |
2 | Penicillin G |
2 | Penetrance |
2 | Pelvis |
2 | Patient Education as Topic |
2 | Patient Compliance |
2 | Papillomaviridae |
2 | Paclitaxel |
2 | Oxygen Consumption |
2 | Oropharyngeal Neoplasms |
2 | Organ Specificity |
2 | Organ Size |
2 | Odds Ratio |
2 | Obesity, Morbid |
2 | Nursing Assessment |
2 | Noonan Syndrome |
2 | Neurocutaneous Syndromes |
2 | Nephrotic Syndrome |
2 | Nepal |
2 | Neoplasms, Second Primary |
2 | Neoplasms, Multiple Primary |
2 | Neglected Diseases |
2 | Necrosis |
2 | Neck |
2 | Nails |
2 | Muscle Strength |
2 | Multimodal Imaging |
2 | Movement Disorders |
2 | Monocytes |
2 | Models, Statistical |
2 | Models, Biological |
2 | Microscopy, Electron |
2 | Microsatellite Repeats |
2 | Mice, Transgenic |
2 | Mesentery |
2 | Mechanotransduction, Cellular |
2 | Mastectomy, Modified Radical |
2 | Lung Neoplasms |
2 | Loiasis |
2 | Logistic Models |
2 | Lod Score |
2 | Liver |
2 | Liver Diseases |
2 | Linear Models |
2 | Leg Dermatoses |
2 | Laryngeal Neoplasms |
2 | Klippel-Trenaunay-Weber Syndrome |
2 | Kidney Transplantation |
2 | Kaplan-Meier Estimate |
2 | Intestinal Mucosa |
2 | Internet |
2 | Interdisciplinary Communication |
2 | Instillation, Drug |
2 | Insecticides |
2 | Inflammation |
2 | In Situ Hybridization |
2 | Immunohistochemistry |
2 | Immunoglobulin E |
2 | Immunity, Innate |
2 | Immunity, Cellular |
2 | Image Interpretation, Computer-Assisted |
2 | Image Enhancement |
2 | Hypotrichosis |
2 | Hypopharyngeal Neoplasms |
2 | Hyperlipidemias |
2 | Hydrochlorothiazide |
2 | Hospitalization |
2 | Horses |
2 | Homozygote |
2 | History, Ancient |
2 | Helminthiasis |
2 | Health Knowledge, Attitudes, Practice |
2 | Hand |
2 | Hand Strength |
2 | Guideline Adherence |
2 | Growth Disorders |
2 | Glomerulonephritis |
2 | Gerbillinae |
2 | Genital Diseases, Female |
2 | Gene Knock-In Techniques |
2 | Gene Expression Regulation, Developmental |
2 | Gene Duplication |
2 | Foot Injuries |
2 | Foot Diseases |
2 | Fibroblasts |
2 | Facial Dermatoses |
2 | Fabry Disease |
2 | Eyelid Diseases |
2 | Extracellular Matrix |
2 | Europe |
2 | Ethiopia |
2 | Esthetics |
2 | Escin |
2 | Erythrocytes |
2 | Endothelium, Lymphatic |
2 | Endoscopy |
2 | Embryonic Development |
2 | Electric Impedance |
2 | Disease Progression |
2 | Disease Management |
2 | Dipetalonema |
2 | Diarrhea |
2 | Diagnostic Imaging |
2 | Developmental Disabilities |
2 | Dermatology |
2 | Dermatitis |
2 | Dengue |
2 | Debridement |
2 | Cyclin-Dependent Kinase 5 |
2 | Cutaneous Fistula |
2 | Craniofacial Abnormalities |
2 | Cosmetic Techniques |
2 | Consensus |
2 | Circumcision, Male |
2 | Chylous Ascites |
2 | Chemotherapy, Cancer, Regional Perfusion |
2 | Cellulitis |
2 | Cell Division |
2 | Cardiomyopathies |
2 | Calcium-Binding Proteins |
2 | Bronchiectasis |
2 | Body Composition |
2 | Blood Proteins |
2 | Blood Flow Velocity |
2 | Biological Evolution |
2 | Benzimidazoles |
2 | Base Sequence |
2 | B-Lymphocytes |
2 | Arthritis, Rheumatoid |
2 | Arteries |
2 | Arterial Occlusive Diseases |
2 | Apoptosis |
2 | Antioxidants |
2 | Antinematodal Agents |
2 | Antigens, CD |
2 | Anesthetics, Local |
2 | Anal Canal |
2 | Ambulatory Care |
2 | Africa |
2 | Aedes |
2 | Adiposis Dolorosa |
1 | gamma-Aminobutyric Acid |
1 | alpha-Glucosidases |
1 | Zebrafish Proteins |
1 | Yellow Nail Syndrome |
1 | Xerostomia |
1 | X-Rays |
1 | X Chromosome |